Myriad Genetics Inc
Myriad Genetics develops molecular diagnostic tests for disease risk assessment and treatment guidance across multiple medical specialties.
424B4Sep 28Latest SEC filing
Sep 16Latest story
Myriad Genetics develops molecular diagnostic tests for disease risk assessment and treatment guidance across multiple medical specialties.